Trinity Biotech Ownership | Who Owns Trinity Biotech?
Trinity Biotech Ownership Summary
Trinity Biotech is owned by 15.70% institutional investors, and 84.30% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Trinity Biotech shares.
TRIB Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Trinity Biotech | 15.70% | - | 84.30% |
Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
Industry | Diagnostics & Research Stocks | 47.68% | 7.65% | 44.68% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2023 | 26 | 30.00% | 6,017,301 | -1.94% | 15 | 6.11% | 6 | 200.00% | 6 | 50.00% |
Sep 30, 2023 | 20 | -9.09% | 6,136,275 | -1.08% | 16 | 6.05% | 2 | -50.00% | 4 | - |
Jun 30, 2023 | 22 | - | 6,203,359 | -1.88% | 16 | 5.91% | 4 | - | 4 | -42.86% |
Mar 31, 2023 | 22 | 10.00% | 6,322,223 | -3.85% | 16 | 5.57% | 4 | -33.33% | 7 | -12.50% |
Dec 31, 2022 | 20 | -4.76% | 6,575,585 | -6.26% | 17 | 5.09% | 6 | 100.00% | 8 | 14.29% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Nasdaq Composite Index | 5.08K | 0.05% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 13, 2004 | ROBERT R MCCORMICK TRIBUNE FOUNDATION | - | Sell | $3.39M |
Feb 17, 2004 | ROBERT R MCCORMICK TRIBUNE FOUNDATION | - | Sell | $4.82M |
Feb 18, 2004 | ROBERT R MCCORMICK TRIBUNE FOUNDATION | - | Sell | $924.52K |
Insider Transactions Trends
Date | Buy | Sell |
---|
TRIB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools